Beta Bionics (BBNX) Enterprise Value (2023 - 2025)
Beta Bionics (BBNX) has disclosed Enterprise Value for 3 consecutive years, with -$219.1 million as the latest value for Q4 2025.
- Quarterly Enterprise Value fell 111.56% to -$219.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$219.1 million through Dec 2025, down 111.56% year-over-year, with the annual reading at -$219.1 million for FY2025, 111.56% down from the prior year.
- Enterprise Value hit -$219.1 million in Q4 2025 for Beta Bionics, up from -$228.7 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$13.0 million in Q2 2024 to a low of -$249.7 million in Q2 2025.
- Historically, Enterprise Value has averaged -$131.3 million across 3 years, with a median of -$103.6 million in 2024.
- Biggest five-year swings in Enterprise Value: decreased 7.06% in 2024 and later plummeted 1816.65% in 2025.
- Year by year, Enterprise Value stood at -$96.7 million in 2023, then fell by 7.06% to -$103.6 million in 2024, then plummeted by 111.56% to -$219.1 million in 2025.
- Business Quant data shows Enterprise Value for BBNX at -$219.1 million in Q4 2025, -$228.7 million in Q3 2025, and -$249.7 million in Q2 2025.